OVER the past few quarters, larger FMCG players have increased their advertising and promotional spends and reduced price per unit quantity in a bid to stay ahead of competition.
Vishal Retail, which has been reporting operating loss for the past six quarters following the poor show by its retail venture, proposed to sell its core retail business to the Shriram Group.
The latest verdict of the Israeli Supreme Court will enable Sun Pharma to increase its stake in Taro to around 53 per cent.
Over the past few years, Tata Global Beverages (TGB) has transformed itself from a tea plantation company to a marketing company.
Ranbaxy Laboratories' stock price has reeled under the pressure of regulatory bans imposed by the US drug regulator on its manufacturing facilities.
Britannia’s profitability suffered during the June 2010 quarter even though its topline continued to grow in double digits.
Nestle India has weathered a challenging environment of high agro-commodity prices and food inflation during the June ’10 quarter.
The Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past one month.
The battle for Parkway is getting increasingly competitive as the two players — Fortis Healthcare and Khazanah — struggle to out-bid each other.
The stock of Hyderabad-based Natco Pharma has earned impressive returns over the past six months compared with the gains in broader market indices.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon